<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with <z:hpo ids='HP_0012133'>erythroid hypoplasia</z:hpo>, a rare form of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, has not yet been clearly defined </plain></SENT>
<SENT sid="1" pm="."><plain>We report four patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0012133'>erythroid hypoplasia</z:hpo> who received immunosuppressive therapy </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were elderly, had severe transfusion-dependent <z:hpo ids='HP_0001903'>anaemia</z:hpo>, morphological evidence of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and a low percentage (3.2-13.6%) of erythroid precursors </plain></SENT>
<SENT sid="3" pm="."><plain>Administration of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA) improved their <z:hpo ids='HP_0001903'>anaemia</z:hpo>; <z:hpo ids='HP_0000001'>all</z:hpo> transfusion-dependent patients achieved transfusion-independence </plain></SENT>
<SENT sid="4" pm="."><plain>An inverted CD4/8 ratio was seen in three patients who also demonstrated T-cell receptor (TCR)-beta and -gamma gene rearrangements by Southern blotting and clonality by polymerase chain reaction </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with CsA can be an attractive alternative treatment for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0012133'>erythroid hypoplasia</z:hpo>, which may be associated with a clonal abnormality in T cells </plain></SENT>
</text></document>